Pre Exposure Prophylaxis News and Research

RSS

U.S.-funded global effort appears to reduce incidence of new HIV infections

A steep drop in the local incidence of new HIV infections accompanied the rollout of a U.S.-funded anti-HIV program in a large East-African population, according to a study led by researchers at Johns Hopkins Bloomberg School of Public Health and Johns Hopkins School of Medicine.

30 Nov 2017

Over half of reported HIV diagnoses in Europe happen in late stage of infection

The WHO European Region is the only Region worldwide where the number of new HIV infections is rising. With more than 160 000 people newly diagnosed with HIV across the Region, including more than 29 000 new cases from the European Union and European Economic Area, this trend continued in 2016.

29 Nov 2017

New HIV prevention guidelines from Canada released

New guidelines for Canada have been published in the Canadian Medical Association Journal online this week that outline the use of new anti-HIV medications among high risk populations who are at risk of contracting HIV from getting the dreaded infection. These new guidelines aim to provide the clinicians with resources and support he added.

27 Nov 2017

New Canadian guideline outlines cost-effective strategies to prevent HIV in high-risk population

A new Canadian guideline outlines how new biomedical strategies to prevent HIV infection can best be used in high-risk populations both before and after exposure to the virus.

27 Nov 2017

Gonorrhea and syphilis cases rise in Australia

The Annual Surveillance Report on HIV, viral hepatitis and sexually transmissible infections (STIs) in Australia was released and it revealed that there is a rise in diagnosis of gonorrhea and syphilis but the number of people being affected by HIV has plateaued. In addition tens of thousands of people have been cured of Hepatitis C. The report comes from the Kirby Institute at UNSW Sydney.

5 Nov 2017

Study: PrEP program for men who have sex with men could lead to long-term cost savings

Providing pre-exposure prophylaxis (PrEP) medication to men who have sex with men who are at high risk of HIV infection (equivalent to less than 5% of men who have sex with men at any point in time) in England would be cost-effective, and could help to prevent up to one in four cases of HIV, according to a study published in The Lancet Infectious Diseases journal.

19 Oct 2017

HIV pre-exposure prophylaxis (PrEP) could be cost saving for NHS in long run

For men who have sex with men in the UK, a programme that involved providing pre-exposure prophylaxis (PrEP) treatment for HIV could be cost effective and cost saving finds a new study. The economic evaluation was made by a team led by Valentina Cambiano, of University College London and published in the latest issue of Lancet Infectious Diseases.

18 Oct 2017

HIV prevention drug to be trialed by Britain's NHS

After a High Court case, an HIV prevention drug is soon to be available on the NHS. NHS England has issued a statement saying that pre-exposure prophylaxis (PrEP) treatment for HIV shall be available to an initial 10,000 people for a trial period of three years.

3 Aug 2017

UNC scientists receive NIH grant to develop new implantable drug delivery system for HIV prevention

Researchers at the University of North Carolina at Chapel Hill have received a three-year, $1.8 million grant from the National Institutes of Health to develop a new implantable drug delivery system for long-lasting HIV-prevention.

25 Mar 2017

Researchers propose new system to evaluate PrEP-based care for HIV prevention

One of the most promising new approaches to slowing the spread of HIV is pre-exposure prophylaxis (PrEP), a once-a-day medication that people who don't have HIV can take to prevent becoming infected.

15 Feb 2017

New antibody drug shows promising results to prevent or treat HIV

A new biologic agent--the most potent of its kind so far--is showing early promise as part of a potential new strategy for treating HIV. The drug, known as 10-1074, may also offer a new way to prevent viral infection in people who are at high risk to acquire HIV, the virus that causes AIDS.

7 Feb 2017

CDC guidelines for PrEP use to prevent HIV transmission do not go far enough, UCLA study suggests

A new study from the UCLA Fielding School of Public Health suggests modifying federal health guidelines related to the use of pre-exposure prophylaxis to prevent HIV transmission because current standards could miss some people who should be on it.

12 Jan 2017

First large-scale clinical study of long-acting injectable HIV drug begins

The first large-scale clinical trial of a long-acting injectable drug for HIV prevention began today.

21 Dec 2016

O'Neill Institute, NMAC release first of two reports to help prevent HIV in communities of color

Two HIV policy experts from the O'Neill Institute for National and Global Health Law at Georgetown Law working in partnership with NMAC have released the first of two reports to help prevent HIV in communities of color.

15 Dec 2016

Study explores men's perceptions of new HIV prevention treatment

The first study to explore United Kingdom men's perceptions of PrEP - a new HIV prevention treatment - has found that their opinions are negatively influenced by social stigma.

8 Dec 2016

Women report experimental vaginal ring for HIV prevention did not negatively affect sexual experience

Most women who used an experimental vaginal ring for HIV prevention report that the physical act of sex was largely unaffected by using the product, which is inserted monthly for continuous wear.

18 Oct 2016

Many gay and bisexual men unaware that PrEP medication may reduce HIV risk

Only four in 10 gay and bisexual men in Baltimore without HIV are aware that pre-exposure prophylaxis medication (PrEP) may significantly reduce their risk of contracting the virus, even those who had recently visited a doctor or been tested for a sexually transmitted disease, new Johns Hopkins Bloomberg School of Public Health research suggests.

5 Oct 2016